Top Markets
Coin of the day
Annovis Bio, Inc. Annovis Bio, Inc.

Annovis Bio, Inc.

ANVS
Rang în acțiuni #23205
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on... Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
Preț acțiune
$1.81
Ultima sincronizare: 2026-08-21
Capitalizare de piață
$77.00M
Schimbare (1 zi)
1.30%
Schimbare (1 an)
-23.63%
Țară
US
Tranzacționează Annovis Bio, Inc. (ANVS)

Categorie

Istoric al prețului acțiunii pentru Annovis Bio, Inc. (ANVS)
Cel mai mare preț de închidere: $1.82 pe 2026-08-01

Cel mai mic preț de închidere: $7.71 pe 2020-01-01
Istoric al prețului acțiunii pentru Annovis Bio, Inc. din 2020 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -38.81%
2025 -26.28%
2024 -55.51%
2023 0.70%
2022 -41.39%
2021 233.32%
2020 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH